MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-31-2025
Butterfly Network Retained Earnings 2011-2026 | BFLY
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Butterfly Network
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -802 M | -730 M | -596 M | -427 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -427 M | -802 M | -639 M |
Quarterly Retained Earnings Butterfly Network
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -864 M | -830 M | -816 M | -784 M | -767 M | -751 M | -686 M | -658 M | -629 M | -596 M | -562 M | - | -472 M | -427 M | -412 M | -398 M | -395 M | -395 M | -395 M | -395 M | -395 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -395 M | -864 M | -581 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.13 | -0.72 % | $ 155 M |  France |
 |
Apyx Medical Corporation
APYX
|
-89.1 M | $ 3.67 | 3.09 % | $ 151 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 7.52 | -2.97 % | $ 1.13 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.22 | 3.26 % | $ 1.35 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 17.81 | 1.37 % | $ 418 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.64 | 7.84 % | $ 67.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 12.82 | 9.76 % | $ 363 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.61 | -0.08 % | $ 38 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 71.86 | 1.32 % | $ 3.92 B |  Britain |
 |
Delcath Systems
DCTH
|
-529 M | $ 11.48 | 2.14 % | $ 411 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Orthofix Medical
OFIX
|
-368 M | $ 11.65 | -3.48 % | $ 461 M |  Curacao |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
-119 M | $ 0.83 | -5.05 % | $ 34.7 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 26.93 | 0.26 % | $ 228 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Profound Medical Corp.
PROF
|
-288 M | $ 6.85 | -4.33 % | $ 207 M | Canada |
 |
Insulet Corporation
PODD
|
287 M | $ 154.16 | -3.89 % | $ 10.8 B | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.35 | -2.08 % | $ 6.52 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 77.95 | -8.37 % | $ 10.5 B | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.76 | -3.52 % | $ 1.14 B | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 285.47 | -2.98 % | $ 109 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 44.26 | -2.87 % | $ 1.3 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 88.12 | 0.23 % | $ 3.06 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 79.96 | -3.44 % | $ 46.8 B | USA |
 |
Tandem Diabetes Care
TNDM
|
-1.25 B | $ 15.48 | -16.19 % | $ 1.05 B | USA |